Tetrabenazine 12.5 MG Oral Tablet — RxCUI 805464
RxNorm drug concept · Semantic clinical drug
RxCUI 805464
Semantic clinical drug · SCD
● Current RxNorm concept 22 FDA products
30 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI805464
Official nameTetrabenazine 12.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped22
Package NDCs mapped30
Reported Medicaid activity (SDUD)5,050 prescriptions · 28 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Tetrabenazine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Tetrabenazine doesn't treat the disease itself — it specifically targets the involuntary, jerky movements called chorea that are a major symptom of Huntington's disease. By reducin...
- What exactly does tetrabenazine do for Huntington's disease?
- It's a very real concern — serious enough that the FDA requires a boxed warning on the label. Tetrabenazine can increase the risk of depression and suicidal thoughts, especially si...
- I heard this medication can cause depression. How serious is that risk?
🕸️ Concept Web — How Tetrabenazine 12.5 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Tetrabenazine 12.5 MG Oral Tablet
RxCUI 805464 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Tetrabenazine
10390IN
-
Tetrabenazine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Xenazine
594629BN
-
Xenazine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Tetrabenazine Oral Tablet
375312SCDF -
Tetrabenazine Oral Product
1164850SCDG -
Tetrabenazine Pill
1164851SCDG -
Tetrabenazine Oral Tablet [Xenazine]
805461SBDF -
Xenazine Oral Product
1186413SBDG -
Xenazine Pill
1186414SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Tetrabenazine Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Tetrabenazine 12.5 MG
805463SCDC -
Tetrabenazine 12.5 MG Oral Tablet [Xenazine]
805466SBD -
Tetrabenazine 12.5 MG [Xenazine]
805465SBDC
-
Tetrabenazine 12.5 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Tetrabenazine 12.5 MG
SCDC · 805463 -
Tetrabenazine Oral Tablet
SCDF · 375312 -
Tetrabenazine Oral Product
SCDG · 1164850 -
Tetrabenazine Pill
SCDG · 1164851
Brand-Name Concepts
-
Tetrabenazine 12.5 MG Oral Tablet [Xenazine]
SBD · 805466 -
Tetrabenazine 12.5 MG [Xenazine]
SBDC · 805465 -
Tetrabenazine Oral Tablet [Xenazine]
SBDF · 805461 -
Xenazine Oral Product
SBDG · 1186413 -
Xenazine Pill
SBDG · 1186414 -
Xenazine
BN · 594629
📦 FDA Products & Package NDCs
22 products · 30 package NDCs
30 package NDCs map to RxCUI 805464 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 27241-0176-13 | 112 TABLET in 1 BOTTLE (27241-176-13) | Tetrabenazine | Ajanta Pharma USA Inc. | 2020-12-27 |
| 27241-0177-13 | 112 TABLET in 1 BOTTLE (27241-177-13) | Tetrabenazine | Ajanta Pharma USA Inc. | 2020-12-27 |
| 31722-0821-11 | 112 TABLET, COATED in 1 BOTTLE (31722-821-11) | Tetrabenazine | Camber Pharmaceuticals, Inc. | 2015-08-17 |
| 31722-0821-31 | 10 TABLET, COATED in 1 BLISTER PACK (31722-821-31) | Tetrabenazine | Camber Pharmaceuticals, Inc. | 2015-08-17 |
| 31722-0821-32 | 100 TABLET, COATED in 1 CARTON (31722-821-32) | Tetrabenazine | Camber Pharmaceuticals, Inc. | 2015-08-17 |
| 31722-0821-56 | 56 TABLET, COATED in 1 BOTTLE (31722-821-56) | Tetrabenazine | Camber Pharmaceuticals, Inc. | 2015-08-17 |
| 31722-0822-11 | 112 TABLET, COATED in 1 BOTTLE (31722-822-11) | Tetrabenazine | Camber Pharmaceuticals, Inc. | 2015-08-17 |
| 31722-0822-31 | 10 TABLET, COATED in 1 BLISTER PACK (31722-822-31) | Tetrabenazine | Camber Pharmaceuticals, Inc. | 2015-08-17 |
| 31722-0822-32 | 100 TABLET, COATED in 1 CARTON (31722-822-32) | Tetrabenazine | Camber Pharmaceuticals, Inc. | 2015-08-17 |
| 31722-0822-56 | 56 TABLET, COATED in 1 BOTTLE (31722-822-56) | Tetrabenazine | Camber Pharmaceuticals, Inc. | 2015-08-17 |
| 43598-0394-05 | 500 TABLET in 1 BOTTLE (43598-394-05) | Tetrabenazine | Dr. Reddys Laboratories Inc | 2018-01-08 |
| 43598-0394-67 | 112 TABLET in 1 BOTTLE (43598-394-67) | Tetrabenazine | Dr. Reddys Laboratories Inc | 2018-01-08 |
| 43598-0395-05 | 500 TABLET in 1 BOTTLE (43598-395-05) | Tetrabenazine | Dr. Reddys Laboratories Inc | 2018-01-08 |
| 43598-0395-67 | 112 TABLET in 1 BOTTLE (43598-395-67) | Tetrabenazine | Dr. Reddys Laboratories Inc | 2018-01-08 |
| 47335-0179-23 | 112 TABLET in 1 BOTTLE (47335-179-23) | Tetrabenazine | Sun Pharmaceutical Industries, Inc. | 2015-08-17 |
| 47335-0277-23 | 112 TABLET in 1 BOTTLE (47335-277-23) | Tetrabenazine | Sun Pharmaceutical Industries, Inc. | 2015-08-17 |
| 51407-0480-12 | 112 TABLET in 1 BOTTLE (51407-480-12) | Tetrabenazine | Golden State Medical Supply, Inc. | 2021-07-26 |
| 51407-0481-12 | 112 TABLET in 1 BOTTLE (51407-481-12) | Tetrabenazine | Golden State Medical Supply, Inc. | 2021-07-26 |
| 60505-3882-07 | 112 TABLET in 1 BOTTLE (60505-3882-7) | Tetrabenazine | Apotex Corp. | 2020-06-18 |
| 60505-3883-07 | 112 TABLET in 1 BOTTLE (60505-3883-7) | Tetrabenazine | Apotex Corp. | 2020-06-18 |
| 67386-0421-01 | 112 TABLET in 1 BOTTLE (67386-421-01) | Xenazine | Lundbeck Pharmaceuticals LLC | 2008-11-24 |
| 67386-0422-01 | 112 TABLET in 1 BOTTLE (67386-422-01) | Xenazine | Lundbeck Pharmaceuticals LLC | 2008-11-24 |
| 68094-0805-10 | 112 TABLET in 1 BOTTLE, PLASTIC (68094-805-10) | Tetrabenazine | Precision Dose Inc. | 2023-12-01 |
| 68094-0905-10 | 112 TABLET in 1 BOTTLE, PLASTIC (68094-905-10) | Tetrabenazine | Precision Dose Inc. | 2023-12-01 |
| 68682-0421-12 | 112 TABLET in 1 BOTTLE (68682-421-12) | tetrabenazine | Oceanside Pharmaceuticals | 2015-07-20 |
| 68682-0422-25 | 112 TABLET in 1 BOTTLE (68682-422-25) | tetrabenazine | Oceanside Pharmaceuticals | 2015-07-20 |
| 69452-0117-21 | 112 TABLET in 1 BOTTLE (69452-117-21) | TETRABENAZINE | Bionpharma Inc. | 2018-01-15 |
| 69452-0118-21 | 112 TABLET in 1 BOTTLE (69452-118-21) | TETRABENAZINE | Bionpharma Inc. | 2018-01-15 |
| 70436-0101-09 | 112 TABLET in 1 BOTTLE (70436-101-09) | tetrabenazine | Slate Run Pharmaceuticals, LLC | 2020-03-02 |
| 70436-0102-09 | 112 TABLET in 1 BOTTLE (70436-102-09) | tetrabenazine | Slate Run Pharmaceuticals, LLC | 2020-03-02 |
Observed labelers:
Camber Pharmaceuticals, Inc. (8) ·
Dr. Reddys Laboratories Inc (4) ·
Ajanta Pharma USA Inc. (2) ·
Apotex Corp. (2) ·
Bionpharma Inc. (2) ·
Golden State Medical Supply, Inc. (2)
· +5 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.